Literature DB >> 7490741

Mapping of the active site zinc ligands of peptide deformylase.

T Meinnel1, C Lazennec, S Blanquet.   

Abstract

A set of 50 site-directed mutants of the Escherichia coli fms gene was constructed to delineate the residues of the active site of peptide deformylase, including the ligands of the zinc ion. In particular, because zinc is usually coordinate by Asp, Cys, Glu or His residues, all the corresponding codons were individually changed. The functional consequence of the substitutions was assessed by complementation of a fms-null strain with the help of vectors expressing the mutate genes. In addition to the mutations of the Cys90 codon, only those of the three conserved residues of the 132HEXXH136 motif of peptide deformylase prevented the indicator strain growing. Most enzyme variants were purified to homogeneity in a second step. Their characterization in vitro showed that the defects in complementation as observed in vivo corresponded to huge decreases of deformylation efficiency. The change of Glu88 also led to a significant decrease in catalytic rate. Unexpectedly, upon substitutions of Glu79 or of Glu83, the enzymes exhibited a strongly increased catalytic efficiency. The measurement of the content of zinc in each purified variant indicated that Cys90, His132 and His136 bound the metal ion. Zinc-free variants mutated at these positions were obtained and shown to display an increased sensitivity to proteolytic attack. Altogether, the data showed that both the presence of zinc and the conserved residues of the HEXXH motif were crucial for the activity of deformylase. This behaviour identified the enzyme as a member of the zinc metalloproteases superfamily. However, the unexpected participation in the binding of the zinc atom of Cys90, upstream from the HEXXH motif, suggested that peptide deformylase could be representative of a new sub-family, distinct from those of thermolysin and astacin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490741     DOI: 10.1006/jmbi.1995.0609

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

Review 1.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

2.  Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene.

Authors:  P S Margolis; C J Hackbarth; D C Young; W Wang; D Chen; Z Yuan; R White; J Trias
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Eukaryotic peptide deformylases. Nuclear-encoded and chloroplast-targeted enzymes in Arabidopsis.

Authors:  L M Dirk; M A Williams; R L Houtz
Journal:  Plant Physiol       Date:  2001-09       Impact factor: 8.340

4.  Peptide deformylase inhibitors as potent antimycobacterial agents.

Authors:  Jeanette W P Teo; Pamela Thayalan; David Beer; Amelia S L Yap; Mahesh Nanjundappa; Xinyi Ngew; Jeyaraj Duraiswamy; Sarah Liung; Veronique Dartois; Mark Schreiber; Samiul Hasan; Michael Cynamon; Neil S Ryder; Xia Yang; Beat Weidmann; Kathryn Bracken; Thomas Dick; Kakoli Mukherjee
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

5.  Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.

Authors:  P Margolis; C Hackbarth; S Lopez; M Maniar; W Wang; Z Yuan; R White; J Trias
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

6.  Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.

Authors:  Sharon Min; Karen Ingraham; Jianzhong Huang; Lynn McCloskey; Sarah Rilling; Anne Windau; Jason Pizzollo; Deborah Butler; Kelly Aubart; Linda A Miller; Magdalena Zalacain; David J Holmes; Karen O'Dwyer
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

7.  Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.

Authors:  Kathrine J Smith; Chantal M Petit; Kelly Aubart; Martin Smyth; Edward McManus; Jo Jones; Andrew Fosberry; Ceri Lewis; Michael Lonetto; Siegfried B Christensen
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

8.  FE(II) is the native cofactor for Escherichia coli methionine aminopeptidase.

Authors:  Sergio C Chai; Wen-Long Wang; Qi-Zhuang Ye
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

9.  N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.

Authors:  Corinne J Hackbarth; Dawn Z Chen; Jason G Lewis; Kirk Clark; James B Mangold; Jeffrey A Cramer; Peter S Margolis; Wen Wang; Jim Koehn; Charlotte Wu; S Lopez; George Withers; Helen Gu; Elina Dunn; R Kulathila; Shi-Hao Pan; Wilma L Porter; Jeff Jacobs; Joaquim Trias; Dinesh V Patel; Beat Weidmann; Richard J White; Zhengyu Yuan
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach.

Authors:  D Chen; C Hackbarth; Z J Ni; C Wu; W Wang; R Jain; Y He; K Bracken; B Weidmann; D V Patel; J Trias; R J White; Z Yuan
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.